Form D · Biotechnology
Tectonic Therapeutic, Inc.
Watertown, MA · CIK 0001856709
Offering snapshot reported Apr 15, 2021 · SEC filing
- Reported sold
- $80.1M Offering amount: $80.1M
- Investors reported
- 23 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Mar 31, 2021 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 15, 2021 | Initial | $80,111,009 | No comparison | 23 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-396054
The Total Offering Amount and the Total Amount Sold include the conversion of $4,054,057.53 of outstanding convertible securities.
Source: Form D, filed Apr 15, 2021. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Christian Cortis | Executive |
| Andrew Kruse | Director |
| Terry Mc Guire | Director |
| Alise Reicin | Director, Executive |
| Timothy A. Springer | Director |
| Praveen Tipirneni | Director |
| Stefan Vitorovic | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
490 Arsenal Way
Watertown, MA, 02472
Watertown, MA, 02472